| Drug Type Therapeutic vaccine | 
| Synonyms Poly-gamma-glutamic acid, poly-γ-glutamic acid, BLS-PGA-C10 | 
| Target- | 
| Action stimulants | 
| Mechanism Immunostimulants, Natural killer cells stimulants(Natural killer cells stimulants) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Uterine Cervical Dysplasia | Phase 3 | China  | - | |
| Uterine Cervical Dysplasia | Phase 3 | South Korea  | - | |
| Uterine Cervical Dysplasia | Phase 3 | - | - | |
| Cervical Intraepithelial Neoplasia | Phase 2 | United States  | 01 Jun 2013 | |
| Colorectal Cancer | Preclinical | South Korea  | 22 Mar 2024 | 
| Phase 2 | 200 | mcoznvjfkq(vmicsqjhuv) = kejgwxvwzc xzfjvfsfbc (litvxczjps ) View more | - | 01 Jul 2018 | |||
| Placebo | mcoznvjfkq(vmicsqjhuv) = irfwgjigse xzfjvfsfbc (litvxczjps ) View more | 





